Iohexol vs. metrizamide

Study of efficacy and morbidity in cervical myelography

Richard E Latchaw, W. L. Hirsch, J. A. Horton, D. Bissonette, D. D. Shaw

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

A double-blind study was conducted in 60 patients undergoing either cervical or more complete myelography via C1-C2 puncture. Patients received either iohexol or metrizamide at a 300 mg l/ml concentration. The contrast media were equally efficacious in the production of high-quality radiographs and CT scans. However, the incidence of adverse reactions differed markedly. Of patients receiving metrizamide, 68% had some type of adverse reaction, whereas only 26% receiving iohexol had symptoms. The incidence of headache (metrizamide, 34%; iohexol, 26%) was not statistically different, but the quality of the headache differed: half of the metrizamide headaches were moderate or severe, whereas all iohexol headaches were mild. Nausea (31%) and vomiting (28%) were common with metrizamide but unusual (3% nausea) with iohexol. Of the metrizamide patients, 21% had overt psychologic changes that did not occur in the iohexol group.

Original languageEnglish (US)
Pages (from-to)931-934
Number of pages4
JournalAmerican Journal of Neuroradiology
Volume6
Issue number6
StatePublished - 1985
Externally publishedYes

Fingerprint

Iohexol
Metrizamide
Myelography
Morbidity
Headache
Nausea
Incidence
Punctures
Double-Blind Method
Contrast Media
Vomiting

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Latchaw, R. E., Hirsch, W. L., Horton, J. A., Bissonette, D., & Shaw, D. D. (1985). Iohexol vs. metrizamide: Study of efficacy and morbidity in cervical myelography. American Journal of Neuroradiology, 6(6), 931-934.

Iohexol vs. metrizamide : Study of efficacy and morbidity in cervical myelography. / Latchaw, Richard E; Hirsch, W. L.; Horton, J. A.; Bissonette, D.; Shaw, D. D.

In: American Journal of Neuroradiology, Vol. 6, No. 6, 1985, p. 931-934.

Research output: Contribution to journalArticle

Latchaw, RE, Hirsch, WL, Horton, JA, Bissonette, D & Shaw, DD 1985, 'Iohexol vs. metrizamide: Study of efficacy and morbidity in cervical myelography', American Journal of Neuroradiology, vol. 6, no. 6, pp. 931-934.
Latchaw, Richard E ; Hirsch, W. L. ; Horton, J. A. ; Bissonette, D. ; Shaw, D. D. / Iohexol vs. metrizamide : Study of efficacy and morbidity in cervical myelography. In: American Journal of Neuroradiology. 1985 ; Vol. 6, No. 6. pp. 931-934.
@article{79688de5f3a24f3e80a9087d18763be4,
title = "Iohexol vs. metrizamide: Study of efficacy and morbidity in cervical myelography",
abstract = "A double-blind study was conducted in 60 patients undergoing either cervical or more complete myelography via C1-C2 puncture. Patients received either iohexol or metrizamide at a 300 mg l/ml concentration. The contrast media were equally efficacious in the production of high-quality radiographs and CT scans. However, the incidence of adverse reactions differed markedly. Of patients receiving metrizamide, 68{\%} had some type of adverse reaction, whereas only 26{\%} receiving iohexol had symptoms. The incidence of headache (metrizamide, 34{\%}; iohexol, 26{\%}) was not statistically different, but the quality of the headache differed: half of the metrizamide headaches were moderate or severe, whereas all iohexol headaches were mild. Nausea (31{\%}) and vomiting (28{\%}) were common with metrizamide but unusual (3{\%} nausea) with iohexol. Of the metrizamide patients, 21{\%} had overt psychologic changes that did not occur in the iohexol group.",
author = "Latchaw, {Richard E} and Hirsch, {W. L.} and Horton, {J. A.} and D. Bissonette and Shaw, {D. D.}",
year = "1985",
language = "English (US)",
volume = "6",
pages = "931--934",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "6",

}

TY - JOUR

T1 - Iohexol vs. metrizamide

T2 - Study of efficacy and morbidity in cervical myelography

AU - Latchaw, Richard E

AU - Hirsch, W. L.

AU - Horton, J. A.

AU - Bissonette, D.

AU - Shaw, D. D.

PY - 1985

Y1 - 1985

N2 - A double-blind study was conducted in 60 patients undergoing either cervical or more complete myelography via C1-C2 puncture. Patients received either iohexol or metrizamide at a 300 mg l/ml concentration. The contrast media were equally efficacious in the production of high-quality radiographs and CT scans. However, the incidence of adverse reactions differed markedly. Of patients receiving metrizamide, 68% had some type of adverse reaction, whereas only 26% receiving iohexol had symptoms. The incidence of headache (metrizamide, 34%; iohexol, 26%) was not statistically different, but the quality of the headache differed: half of the metrizamide headaches were moderate or severe, whereas all iohexol headaches were mild. Nausea (31%) and vomiting (28%) were common with metrizamide but unusual (3% nausea) with iohexol. Of the metrizamide patients, 21% had overt psychologic changes that did not occur in the iohexol group.

AB - A double-blind study was conducted in 60 patients undergoing either cervical or more complete myelography via C1-C2 puncture. Patients received either iohexol or metrizamide at a 300 mg l/ml concentration. The contrast media were equally efficacious in the production of high-quality radiographs and CT scans. However, the incidence of adverse reactions differed markedly. Of patients receiving metrizamide, 68% had some type of adverse reaction, whereas only 26% receiving iohexol had symptoms. The incidence of headache (metrizamide, 34%; iohexol, 26%) was not statistically different, but the quality of the headache differed: half of the metrizamide headaches were moderate or severe, whereas all iohexol headaches were mild. Nausea (31%) and vomiting (28%) were common with metrizamide but unusual (3% nausea) with iohexol. Of the metrizamide patients, 21% had overt psychologic changes that did not occur in the iohexol group.

UR - http://www.scopus.com/inward/record.url?scp=0022388671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022388671&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 931

EP - 934

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 6

ER -